January 20, 2026


At the conclusion, participants should be able to:
1) DESCRIBE the current status of HPV vaccination utilization nationally and in the state of Florida; 2) DISCUSS patient, provider, and systems level barriers to vaccination; 3) IDENTIFY interventions across multiple levels to improve adoption of this cancer prevention vaccine. Questions and answers will allow for audience participation.
© MeCop 2025. All rights reserved